130 related articles for article (PubMed ID: 19966059)
1. Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes.
Pang T; Gan XT; Freeman DJ; Cook MA; Karmazyn M
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H545-53. PubMed ID: 19966059
[TBL] [Abstract][Full Text] [Related]
2. CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.
Gan XT; Taniai S; Zhao G; Huang CX; Velenosi TJ; Xue J; Urquhart BL; Karmazyn M
Mol Cell Biochem; 2014 Sep; 394(1-2):237-46. PubMed ID: 24894822
[TBL] [Abstract][Full Text] [Related]
3. Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes.
Pang T; Rajapurohitam V; Cook MA; Karmazyn M
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1382-90. PubMed ID: 20190100
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes.
Gan XT; Rajapurohitam V; Haist JV; Chidiac P; Cook MA; Karmazyn M
J Pharmacol Exp Ther; 2005 Jan; 312(1):27-34. PubMed ID: 15452191
[TBL] [Abstract][Full Text] [Related]
5. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
Kilić A; Javadov S; Karmazyn M
J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554
[TBL] [Abstract][Full Text] [Related]
6. Distinct KATP channels mediate the antihypertrophic effects of adenosine receptor activation in neonatal rat ventricular myocytes.
Xia Y; Javadov S; Gan TX; Pang T; Cook MA; Karmazyn M
J Pharmacol Exp Ther; 2007 Jan; 320(1):14-21. PubMed ID: 17012605
[TBL] [Abstract][Full Text] [Related]
7. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
Puhl SL; Kazakov A; Müller A; Fries P; Wagner DR; Böhm M; Maack C; Devaux Y
Br J Pharmacol; 2016 Jan; 173(1):88-102. PubMed ID: 26406609
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
10. Miro1 as a novel regulator of hypertrophy in neonatal rat cardiomyocytes.
Conejeros C; Parra V; Sanchez G; Pedrozo Z; Olmedo I
J Mol Cell Cardiol; 2020 Apr; 141():65-69. PubMed ID: 32234389
[TBL] [Abstract][Full Text] [Related]
11. Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes.
Barron AJ; Finn SG; Fuller SJ
Biochem J; 2003 Apr; 371(Pt 1):71-9. PubMed ID: 12513686
[TBL] [Abstract][Full Text] [Related]
12. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
Guo J; Gan XT; Haist JV; Rajapurohitam V; Zeidan A; Faruq NS; Karmazyn M
Circ Heart Fail; 2011 Jan; 4(1):79-88. PubMed ID: 20971938
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy.
Gao S; Liu XP; Wei LH; Lu J; Liu P
Can J Physiol Pharmacol; 2018 Apr; 96(4):352-358. PubMed ID: 28910549
[TBL] [Abstract][Full Text] [Related]
14. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
[TBL] [Abstract][Full Text] [Related]
15. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
[TBL] [Abstract][Full Text] [Related]
16. Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models.
Ozakca I
J Cardiovasc Pharmacol; 2019 Mar; 73(3):155-164. PubMed ID: 30601193
[TBL] [Abstract][Full Text] [Related]
17. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.
Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P
Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124
[TBL] [Abstract][Full Text] [Related]
18. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
19. c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes.
Finn SG; Dickens M; Fuller SJ
Biochem J; 2001 Sep; 358(Pt 2):489-95. PubMed ID: 11513749
[TBL] [Abstract][Full Text] [Related]
20. Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes.
Zeidan A; Gan XT; Thomas A; Karmazyn M
Mol Cell Biochem; 2014 Jan; 385(1-2):239-48. PubMed ID: 24096734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
